BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
CytRx Corporation (CYTR) Announces Research And Development Day And Webcast 4/10/2014 7:14:31 AM    More...
CytRx Corporation (CYTR) To Present Updated Aldoxorubicin Preclinical Glioblastoma Study Results At The 2014 American Association for Cancer Research Annual Meeting 4/3/2014 8:54:08 AM    More...
CytRx Corporation (CYTR) Receives Orphan Medicinal Product Designation From European Commission (EC) For Aldoxorubicin In Soft Tissue Sarcoma 3/31/2014 8:04:35 AM    More...
CytRx Corporation (CYTR) Issues Statement Regarding Recent Lawsuits 3/27/2014 9:12:52 AM    More...
CytRx Corporation (CYTR) Initiates Pivotal Global Phase 3 Clinical Trial With Aldoxorubicin For Second-Line Treatment Of Soft Tissue Sarcoma 3/24/2014 8:46:25 AM    More...
CytRx Corporation (CYTR) Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/5/2014 10:09:11 AM    More...
CytRx Corporation (CYTR) to Present at the 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 10, 2014, In New York City 2/3/2014 6:55:00 AM    More...
CytRx Corporation (CYTR) Announces Proposed Public Offering of Common Stock 1/31/2014 7:04:35 AM    More...
CytRx Corporation (CYTR) Receives FDA Approval To Extend Aldoxorubicin Dosing Cycles Until Disease Progression In Upcoming Pivotal, Global Phase 3 Trial For Soft Tissue Sarcomas 1/21/2014 9:32:24 AM    More...
MissionIR Interview With CytRx Corporation (CYTR) Embellishes On Clinical Trial Results And Plans For An Incredible 2014 1/16/2014 10:09:27 AM    More...
12345678910...